Yahoo Finance

NEO Battery Materials Ltd., a developer of low-cost silicon anode materials for lithium-ion batteries, has appointed Dr. Matthew Dawson, CEO of Elementium Materials, as a Senior Scientific Advisor. Dr. Dawson's extensive background in advancing energy transition technologies is expected to bring valuable insights and support to NEO's commercialization of its battery technology. This development highlights the ongoing advancements in the field of electric vehicle battery materials, particularly in enhancing battery performance and reducing costs, potentially impacting the broader electric vehicle industry by propelling innovations in longer-lasting and faster-charging batteries.

In other market news, Zhejiang Leapmotor Technology was trading firmly up 7.0% and finishing the session at HK$59.55, near its 52-week high. In the meantime, Magna International lagged, down 5.8% to end the day at CA$45.69. On Friday, the company raised its earnings guidance for 2025, expecting sales between $40.0 billion and $41.6 billion.

Magna International's strategic moves towards restructuring and market expansion may soon elevate its margins and earnings, creating a critical opportunity for investors amidst potential macroeconomic pressures. Discover the full narrative of these timely developments and their implications by clicking here.

Previously, our Market Insights article, "Automakers Caught in the Tariff Crossfire," explored the pressures on the auto industry amid rising tariffs and the implications for electric vehicle sales, investments, and opportunities. Catch up now before the market shifts further!

Best EV Stocks

• BYD finished trading at HK$382.40 up 3.3%.

• Tesla finished trading at $287.21 up 2.4%.

• Ford Motor settled at $10.28 up 1%. Ford Motors is set to present at the Milken Institute Global Conference 2025 in Los Angeles today.

Taking Advantage

• Dive into all 49 of the EV Stocks we have identified, like Changzhou Xingyu Automotive Lighting SystemsLtd, Elite Material and Mobileye Global, right here.

• Curious About Other Options? AI is about to change healthcare. These 25 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.